https://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-149358831/news/New-England-Journal-of-Medicine-publishes-Phase-III-data-showing-Xolair-significantly-reduced-allerg-46025064/?utm_source=telegram&utm_medium=social&utm_campaign=share